• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCIENCES PR BIOPATCH, UNKNOWN SIZE/PRODUCT ID; ANTIMICROBIAL PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCIENCES PR BIOPATCH, UNKNOWN SIZE/PRODUCT ID; ANTIMICROBIAL PRODUCTS Back to Search Results
Catalog Number XXX-BIOPATCH
Device Problems Device Operates Differently Than Expected (2913); Appropriate Term/Code Not Available (3191)
Patient Problems Irritation (1941); Itching Sensation (1943); Skin Irritation (2076); Fluid Discharge (2686)
Event Type  Injury  
Manufacturer Narrative
The device involved in the reported incident is not available for evaluation.An investigation has been initiated based on the reported information.
 
Event Description
The journal of heart and lung transplantation (2012) published "improving patient satisfaction in wound care of left ventricular assist device exit sites".The authors reviewed their experience with modifications on exit site dressings and application of external treatments.Thirty patients with heartware left ventricular assist devices were selected within the study group.The patients were split into 2 groups: group 1 (n=14) using a foam chlorhexidine impregnated ring (biopatch) to driveline exit site from time of implantation up to 18 months postoperative; group 2 (n=16) received an alginate gel (flaminal hydro) only dressings to exit site from implantation to 9 months post-operative.Patients in group 1 reported that whilst using the chlorhexidine ring, wounds were irritated, itchy and produced considerable exudate.Twelve of these patients found a significant improvement in the appearance and healing of their wound when changed to alginate gel.Only one positive wound culture was obtained with staph aureus, which became negative when this was repeated with alginate gel.
 
Manufacturer Narrative
Integra has completed their internal investigation on january 19, 2018.Results: no sample will be returned for evaluation since units involved in the reported incident were used during a medical study performed during undetermined period and are not available.In addition, no pictures of skin condition were provided; therefore, the event/condition could not be confirmed.Dhr review; could not be performed since no catalog /lot number was reported.Complaints history; upon review of integra's complaint system from december 2015 ¿ january 2018, a total of 43 complaints for biopatch product family, including the one being investigated throughout this report, related to skin irritation and/or adverse reaction were evaluated.(b)(4).Conclusion: no assignable cause that could be associated to the manufacturing process of biopatch was identified.However, biopatch¿s ifu literature recognizes the possibility of an adverse reaction and to not use product on children under 16 years of age.The ifu warns: ¿ ¿adverse reactions to chlorhexidine gluconate such as dermatitis, hypersensitivity, and generalized allergic reactions are very rare, but if any such reactions occur, discontinue use of the dressing immediately.¿ ¿ the safety and effectiveness of biopatch has not been established in children under 16 years of age.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOPATCH, UNKNOWN SIZE/PRODUCT ID
Type of Device
ANTIMICROBIAL PRODUCTS
Manufacturer (Section D)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
road 402 north, km 1.2
anasco PR 00610
Manufacturer (Section G)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
anasco PR 00610
Manufacturer Contact
sonia irizarry
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key7143144
MDR Text Key95722063
Report Number2648988-2017-00064
Device Sequence Number1
Product Code FRO
Combination Product (y/n)N
PMA/PMN Number
K003229
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberXXX-BIOPATCH
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/19/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-